16.40
16.40 (0%)
As of Feb 14, 2025
Viridian Therapeutics, Inc.\DE [VRDN]
Source:
Company Overview
Viridian Therapeutics, Inc is a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases. We target disease areas where marketed therapies often leave room for improvements in efficacy, safety, and/or dosing convenience.
Country | United States |
Headquarters | waltham, massachusetts |
Phone Number | 617.272.4600 |
Industry | services |
CEO | Stephen Mahoney |
Website | www.viridiantherapeutics.com |